Antibody Information
General Information of This Antibody
| Antibody ID | ANTI0RQWMA |
|||||
|---|---|---|---|---|---|---|
| Antibody Name | hIMB1636 |
|||||
| Organization | Chinese Academy of Medical Sciences and Peking Union Medical College. |
|||||
| Synonyms |
hIMB1636
Click to Show/Hide
|
|||||
| Antibody Type | Monoclonal antibody (mAb) |
|||||
| Antibody Subtype | Humanized lgG |
|||||
| Antigen Name | Tumor-associated calcium signal transducer 2 (TACSTD2) |
Antigen Info | ||||
| Click to Show/Hide the Sequence Information of This Antibody | ||||||
Each Antibody-drug Conjugate Related to This Antibody
Full Information of The Activity Data of The ADC(s) Related to This Antibody
hIMB1636-MMAE [Investigative]
Revealed Based on the Cell Line Data
| Experiment 1 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.24۪.17 nM
|
High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Skin squamous cell carcinoma | A431 cells | CVCL_0037 | ||
| Experiment 2 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.43۪.48 nM
|
Moderate TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | HCC827 cells | CVCL_2063 | ||
| Experiment 3 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.68۪.31 nM
|
Moderate TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Esophageal squamous cell carcinoma, Squamous cell carcinoma of the esophagus | KYSE150 cells | CVCL_1348 | ||
| Experiment 4 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
0.73۪.21 nM
|
High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | BxPC-3 cells | CVCL_0186 | ||
| Experiment 5 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
1.22۪.48 nM
|
High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | T3M4 cells | CVCL_4056 | ||
| Experiment 6 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
1.55۪.17 nM
|
Moderate TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-468 cells | CVCL_0419 | ||
| Experiment 7 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
2.81۪.06 nM
|
High TROP2 expression (TROP2++) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Hypopharyngeal squamous cell carcinoma | FaDu cells | CVCL_1218 | ||
| Experiment 8 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
15.02۪.09 nM
|
Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Esophageal squamous cell carcinoma, Squamous cell carcinoma of the esophagus | Eca109 cells | CVCL_6898 | ||
| Experiment 9 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) |
15.86۪.51 nM
|
Low TROP2 expression (TROP2+) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Invasive breast carcinoma | MCF-7 cells | CVCL_0031 | ||
| Experiment 10 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Pancreatic ductal adenocarcinoma | AsPC-1 cells | CVCL_0152 | ||
| Experiment 11 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Breast adenocarcinoma | MDA-MB-231 cells | CVCL_0062 | ||
| Experiment 12 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Colon cancer | HT29 cells | CVCL_A8EZ | ||
| Experiment 13 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Colon carcinoma | HCT116 cells | CVCL_0291 | ||
| Experiment 14 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Low TROP2 expression (TROP2+) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Colon adenocarcinoma | SW480 cells | CVCL_0546 | ||
| Experiment 15 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Lung large cell carcinoma | H460 cells | CVCL_0459 | ||
| Experiment 16 Reporting the Activity Date of This ADC | [1] | ||||
| Efficacy Data | Half Maximal inhibitory Concentration (lC50) | > 100 nM | Negative TROP2 expression (TROP2-) | ||
| Method Description |
The cytotoxicity of hIMB1636-MMAE and free MMAE was evaluated by the Cell Counting Kit-8 (CCK-8) assay (Dojindo, Kyushu, Japan). Cells were plated at 2 × 103 to 8 × 103 cells/well in 100 uL culture medium into 96-well plates. Following an overnight incubation at 37 °C, the cells were cultured continuously for 48 h in 100 uL of medium containing various concentrations of drugs (100, 10, 1, 0.1, 0.01, and 0.001 nM). Then, the medium was replaced with 100 uL of fresh medium containing 10% CCK-8 reagent and incubated for 1 h. The absorbance was measured at 450 nm by a SpectraMax i3x Multi-Mode microplate reader (Molecular Devices, LLC, USA). The half-maximal inhibitory concentration (IC50) of the samples was calculated by Prism GraphPad 6.0 (GraphPad Software, San Diego, CA). The data are presented as the mean ± SD for three independent experiments.
Click to Show/Hide
|
||||
| In Vitro Model | Lung adenocarcinoma | A549 cells | CVCL_0023 | ||
References
